Therapeutic effect of antiplatelet agents on obstructive vascular lesions after kidney transplantation with cyclosporine.
Teraoka
S
S
Oba
S
S
Takahashi
K
K
Yagisawa
T
T
Yamaguchi
Y
Y
Sanaka
T
T
Tanabe
K
K
Kawai
T
T
Fuchinoue
S
S
Honda
H
H
D000179:Acrylates / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D003524:Cyclosporins / Q000008:administration & dosage*; D011464:Epoprostenol / Q000627:therapeutic use* / Q000031:analogs & derivatives; D005260:Female; D006084:Graft Rejection; D006085:Graft Survival / Q000187:drug effects; D006801:Humans; D007668:Kidney / Q000098:blood supply / Q000473:pathology; D016030:Kidney Transplantation; D008297:Male; D008689:Methacrylates / Q000627:therapeutic use*; D008875:Middle Aged; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors*; D013988:Ticlopidine / Q000627:therapeutic use*
D000179:Acrylates; D003524:Cyclosporins; D008689:Methacrylates; D011464:Epoprostenol; D013930:Thromboxane-A Synthase; C034364:ozagrel; C035847:ataprost; D013988:Ticlopidine